Corona Remedies CFO shares growth guidance
Corona Remedies has guided for 15% organic revenue growth, with any contribution from future acquisitions expected to be incremental. The company also expects profit after tax (PAT) to grow at around 20% annually over the next three to five years, reflecting its confidence in sustaining long-term earnings growth. Chief Financial Officer Bhavin Bhagat said” “We…
